ライフサイエンスコーパス: PAMP

1 PAMP binding activates RIG-I to induce innate immune sig

2 PAMP perception leads to BIR2 release from the BAK1 comp

3 PAMP recognition of T/F HCV variants by RIG-I may theref

4 PAMP responses include changes in intracellular protein

5 A PAMP selectivity test was carried out in line with our i

6 e-stranded RNA of bacterial origin acts as a PAMP and activates NOS2 by engaging TLR-7.

7 CV-infected liver and has features of both a PAMP and a genomic reservoir.

8 plies that the immune response elicited by a PAMP is more complex than predicted by the examination o

9 We thus identify a PAMP-independent mechanism of immune stimulation and hig

10 ctosaminogalactan (GAG) of A. fumigatus is a PAMP that activates the NLRP3 inflammasome.

11 ciently present Ags linked to the activating PAMP and prime naive T cells.

12 s represents the first description of active PAMP masking by a Candida species, a process that reduce

13 agocytosed and degraded by constitutive- and PAMP-dependent LC3-assisted phagocytosis and does not in

14 tential target to treat stroke and DAMP- and PAMP-induced inflammation.

15 EG3 acted as PAMPs to trigger cell death and PAMP-triggered immunity (PTI) independent of their enzym

16 Mitochondrial DAMPs and PAMPs share the same pattern recognition receptors.

17 gen-associated molecular patterns (DAMPs and PAMPs).

18 ceptors (TLRs) that recognize such DAMPs and PAMPs, or the downstream effector molecules they engende

19 hamiana and cotton, VdEG1 and VdEG3 acted as PAMPs and virulence factors, respectively indicative of

20 lium dahliae Vd991, VdEG1 and VdEG3 acted as PAMPs to trigger cell death and PAMP-triggered immunity

21 hat recognize the long stretches of dsRNA as PAMPs to activate interferon-mediated antiviral pathways

22 als--immutable molecular structures known as PAMPs.

23 ort the identification of a novel Ascomycete PAMP, RcCDI1, recognized by Solanaceae but not by monoco

24 n of a special class of viability-associated PAMPs (vita-PAMPs).

25 c analyses demonstrate that CPK28 attenuates PAMP-triggered immune responses and antibacterial immuni

26 F-Tu receptor (EFR) recognizes the bacterial PAMP elongation factor Tu (EF-Tu) and its derived peptid

27 and PG-LPS prior to stimulation by bacterial PAMPs.

28 only the continuous expression of bacterial PAMPs on transgenic T. cruzi sustains these responses, r

29 ther this symmetry in host responses between PAMPs and DAMPs extends to metabolic shifts is unclear.

30 calcium-dependent protein kinases, and both PAMP-induced BIK1 activation and BIK1-mediated phosphory

31 Our results suggested activation of both PAMP-triggered basal defense and disease resistance (R)

32 vivo phosphorylation of RBOHD occurs on both PAMP- and ROS stimulation.

33 Both PAMPs and DAMPs can be liberated by early insults to the

34 tis cinerea and Alternaria brassisicola Both PAMPs and osmotic stress activate some of the same MPKs

35 st, EBOV VP35 can inhibit activation by both PAMPs.

36 Confirming our idea that both PAMPs and DAMPs are likely to cooccur at infection sites

37 that IRGM expression, which is increased by PAMPs, DAMPs, and microbes, can suppress the pro-inflamm

38 In vitro, hepcidin induction by PAMPs in primary human hepatocytes was abolished by the

39 he ability to map NOS2 activity triggered by PAMPs can reveal critical mechanisms underlying pathogen

40 targeted inactivation of a broadly conserved PAMP.

41 or DCs in the GI tract are activated by DAMP/PAMP signals in the colon that gain access to the lamina

42 athogen-associated molecular patterns (DAMPs/PAMPs) from blood with high efficiency (92-99%).

43 ent status is critical for calcium-dependent PAMP-triggered immunity in plants.

44 lant upon treatment with a bacterial-derived PAMP, flg22.

45 meability, the release of microbiota-derived PAMPs, and inflammation.

46 splay precise stoichiometries of any desired PAMP.

47 n is down-regulated in response to different PAMPs.

48 Insights on differential PAMP recognition and inhibition of IFN induction by a si

49 5 are essential PRRs that recognize distinct PAMPs that accumulate during WNV replication.

50 phorylation in the regulation of MKP1 during PAMP signaling and resistance to bacteria.

51 We found that MKP1 was phosphorylated during PAMP elicitation and that phosphorylation stabilized the

52 planta expressed HopM1 suppresses two early PAMP-triggered responses, the oxidative burst and stomat

53 e mkp1 mutant lacking MKP1 displays enhanced PAMP responses and resistance against the virulent bacte

54 position and the gut barrier and exaggerated PAMP translocation and liver damage.

55 rthe oryzae and Neurospora crassa, exhibited PAMP activity, inducing cell death in Solanaceae but not

56 ng of and transgenic expression of exogenous PAMPs all result in enhanced early adaptive immune respo

57 o phosphorylated by MPK4 and, upon flagellin PAMP treatment, PAT1 accumulates and localizes to cytopl

58 ponses induced by the elf18, pep1, and flg22 PAMP/DAMPs, including resistance to P. syringae and B. c

59 he nucleus, whose levels increased following PAMP treatment or infection with an avirulent pathogen.

60 cell surface TLR2, requiring degradation for PAMP recognition.

61 proteins, CNGC2 and CNGC4, are essential for PAMP-induced calcium signalling in Arabidopsis(3-7).

62 identify LRR-type RKs and RLPs required for PAMP perception/responsiveness, even when the active pur

63 function of 14-3-3 proteins is required for PAMP-triggered oxidative burst and stomatal immunity, an

64 In addition, a role for PAMP and DAMP perception in bolstering effector-triggere

65 g been recognized as an essential signal for PAMP-triggered immunity in plants, the mechanism of PAMP

66 A direct role for PAMPs in TLR activation was not supported in a transacti

67 Arabidopsis has at least four PAMP/pathogen-responsive MAPKs: MPK3, MPK6, MPK4 and MPK

68 However, the Aspergillus fumigatus PAMPs that are responsible for inflammasome activation a

69 We characterized a novel fungal PAMP, Cell Death Inducing 1 (RcCDI1), identified in the

70 This activation in response to the fungal PAMP chitin requires a chitin receptor and one or more M

71 e BAK1-independent recognition of the fungal PAMP chitin.

72 ribosomes connect the sensing of this fungal PAMP to the activation of an innate immune response.

73 fferent methods that can be used to identify PAMPs/DAMPs and PRRs.

74 ovel specific requirement for AO activity in PAMP-triggered RBOHD-dependent ROS burst and stomatal im

75 However, bsk5 plants were not affected in PAMP/DAMP activation of mitogen-activated protein kinase

76 or some, but not all, of MKP1's functions in PAMP responses and defense against bacteria.

77 ansgenically expressing HopK1 are reduced in PAMP-triggered immune responses compared with wild-type

78 Consistent with its role in PAMP-triggered immunity, CRT1 interacted with the PAMP r

79 disease resistance to bacteria and increased PAMP-triggered immunity (PTI) responses, which are resto

80 ociated molecular patterns (PAMPs) to induce PAMP-triggered immunity (PTI) also restricts T3SS effect

81 function experiments show that HBI1 inhibits PAMP-induced growth arrest, defense gene expression, rea

82 gens avoid activating NOS2 by concealing key PAMPs from their cognate TLRs.

83 However, in contrast to other known PAMPs/DAMPs, cellobiose stimulates neither detectable re

84 Here, we comprehensively review known PAMPs/DAMPs recognized by plants as well as the plant PR

85 enic Escherichia coli (CFT073) and microbial PAMPs including flagellin, LPS and peptidoglycan.

86 systemic inflammation triggered by molecular PAMPs, inflammasome component NLRP3 mutation, and ASC da

87 se to a panel of pathogen-derived molecules (PAMPs) in mice and human primary hepatocytes.

88 ogen-associated molecular pattern molecules (PAMPs) are derived from microorganisms and recognized by

89 ogen-associated molecular pattern molecules (PAMPs) elicited a normal response; however, NF-kappaB-me

90 ogen-associated molecular pattern molecules (PAMPs) including bacterial endotoxin, respiratory viruse

91 ogen-associated molecular pattern molecules (PAMPs) such as LPS activate the endothelium and can lead

92 ogen-associated molecular pattern molecules (PAMPs), which are recognized by pattern recognition rece

93 Most PAMPs and DAMPs serve as so-called 'Signal 0s' that bind

94 ), is intrinsically adjuvanted with multiple PAMPs and induces a vigorous anti-WNV humoral response.

95 tions in MHC-like molecule(s) that bound new PAMP(s) would not be recognized by original TCR-like mol

96 report the existence of a completely novel "PAMP" that is not a molecular structure but an antigenic

97 set of bioassays to study the activation of PAMP-triggered immunity (PTI) in wheat.

98 of Exo70B2 contributes to the attenuation of PAMP-induced signaling.

99 knowledge about the spatial distribution of PAMP-induced Ca(2+) signals is limited.

100 iggered immunity in plants, the mechanism of PAMP-induced calcium signalling remains unknown(1,2).

101 with BIR2 acting as a negative regulator of PAMP-triggered immunity by limiting BAK1-receptor comple

102 h PUB23 and PUB24 as a negative regulator of PAMP-triggered responses.

103 ignaling, the regulation and significance of PAMP-induced ion fluxes in immunity remain unknown.

104 basal resistance, i.e., poor suppression of PAMP-triggered defense by effectors.

105 tin proteasome system for the suppression of PAMP-triggered immunity in plants.

106 ation of airborne fungi, surface exposure of PAMPs and melanin removal, are necessary for LAP activat

107 Surface exposure of PAMPs during germination can leave the pathogen vulnerab

108 requirement for the continuous expression of PAMPs for optimal anti-pathogen immunity.

109 The interactions of PAMPs and DAMPs require further investigation in dental/

110 se deposition independent of the presence of PAMPs.

111 by signal two, which involves recognition of PAMPs or damage-associated molecular patterns (DAMPs), s

112 us and sterile injuries cause the release of PAMPs and DAMPs.

113 ts ability to sense the widest repertoire of PAMPs owing to its heterodimerization with either TLR1 o

114 ition receptor that recognizes many types of PAMPs that originate from gram-positive bacteria.

115 distinct from that triggered by the oomycete PAMP INF1.

116 tion, which we find can be primed with other PAMPs, including hepatitis C virus RNA.

117 es as pathogen-associated molecular pattern (PAMP) and is a potent immune stimulator for innate immun

118 nized pathogen-associated molecular pattern (PAMP) capable of activating a type I IFN response via th

119 erial pathogen-associated molecular pattern (PAMP) counterpart, has been achieved using hybridized to

120 erial pathogen-associated molecular pattern (PAMP) driving host type I IFN responses and autophagy.

121 a key pathogen-associated molecular pattern (PAMP) during infection.

122 f the pathogen-associated molecular pattern (PAMP) encountered by endogenous DC.

123 a key pathogen-associated molecular pattern (PAMP) located at the cell surface of C. albicans and oth

124 and a pathogen-associated molecular pattern (PAMP) motif located within the 3' untranslated region co

125 major pathogen-associated molecular pattern (PAMP) of extracellular gram-positive bacteria, via ester

126 have pathogen-associated molecular pattern (PAMP) receptors for dsRNA because of the presence of hos

127 cific pathogen-associated molecular pattern (PAMP) recognition pathways, we determined that the dampe

128 ommon pathogen-associated molecular pattern (PAMP) recognized by TLR7.

129 , and pathogen-associated molecular pattern (PAMP) signals repress HBI1 transcription.

130 e and pathogen-associated molecular pattern (PAMP) stimulation had a strong cooperative effect on mac

131 se to pathogen-associated molecular pattern (PAMP) stimulation.

132 PTI [pathogen associated molecular pattern (PAMP) triggered immunity] reaction.

133 major pathogen-associated molecular pattern (PAMP), beta-glucan.

134 NA, a pathogen-associated molecular pattern (PAMP), comprised 52% (standard deviation, 28%) of the HC

135 erial pathogen-associated molecular pattern (PAMP), flagellin (flg22).

136 (DC) pathogen-associated molecular pattern (PAMP)-induced pro-inflammatory cytokine production, inhi

137 tween pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) and brassinosteroid (BR)-

138 FR in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) and the LRR-RLK BRI1 in b

139 ) and pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) responses already charact

140 arms: pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI), induced by surface-local

141 nt is pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI).

142 uring pathogen-associated molecular pattern (PAMP)-triggered immunity in plants.

143 press pathogen-associated molecular pattern (PAMP)-triggered immunity in rice.

144 d for pathogen-associated molecular pattern (PAMP)-triggered immunity, basal resistance, non-host res

145 ndent pathogen-associated molecular pattern (PAMP).

146 ed by pathogen-associated molecular pattern (PAMP)/damage-associated molecular pattern (DAMP) signals

147 tors, pathogen-associated molecular pattern (PAMPs) subsequently inform the polarization of downstrea

148 nize pathogen-associated molecular patterns (PAMP) and mediate innate immune responses, and TLR agoni

149 s to pathogen-associated molecular patterns (PAMP), enhanced cell death, and resistance to bacterial

150 en- or damage-associated molecular patterns (PAMP/DAMPs) and initiate pattern-triggered immunity (PTI

151 n- and damage-associated molecular patterns (PAMPs and DAMPs) orchestrate inflammatory responses to i

152 en- or danger-associated molecular patterns (PAMPs or DAMPs).

153 Pathogen-associated molecular patterns (PAMPs) activate innate immunity in both animals and plan

154 rved pathogen-associated molecular patterns (PAMPs) and activate MAP kinase cascades, which regulate

155 nize pathogen-associated molecular patterns (PAMPs) and activate signaling pathways that lead to immu

156 e as pathogen-associated molecular patterns (PAMPs) and bind pattern recognition receptors to stimula

157 nize pathogen-associated molecular patterns (PAMPs) and damaged-associated molecular patterns (DAMPs)

158 nous pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs)

159 rous pathogen-associated molecular patterns (PAMPs) and have been shown to combat various viral, para

160 s as pathogen-associated molecular patterns (PAMPs) and initiate an antiviral immune response.

161 n of pathogen-associated molecular patterns (PAMPs) and other environmental stresses trigger transien

162 n of pathogen-associated molecular patterns (PAMPs) and recognition by the host Pto kinase of pathoge

163 e of pathogen-associated molecular patterns (PAMPs) and their binding to pattern recognition receptor

164 d by pathogen-associated molecular patterns (PAMPs) and undergo maturation.

165 Pathogen-associated molecular patterns (PAMPs) are detected by plant pattern recognition recepto

166 Pathogen-associated molecular patterns (PAMPs) are known to be fundamental in instigating immune

167 s to pathogen-associated molecular patterns (PAMPs) are mediated by cell surface pattern recognition

168 zing pathogen-associated molecular patterns (PAMPs) but have also been implicated in the recognition

169 rved pathogen-associated molecular patterns (PAMPs) by host pattern recognition receptors (PRRs) resu

170 cing pathogen-associated molecular patterns (PAMPs) by influenza A viruses using inhibitors of these

171 n of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs).

172 n of pathogen-associated molecular patterns (PAMPs) by pattern-recognition receptors (PRRs) located o

173 n of pathogen-associated molecular patterns (PAMPs) by surface-localized pattern recognition receptor

174 n of pathogen-associated molecular patterns (PAMPs) by surface-localized pattern recognition receptor

175 n of pathogen-associated molecular patterns (PAMPs) by surface-localized pattern-recognition receptor

176 s) or pattern-associated molecular patterns (PAMPs) by the innate immune system.

177 inct pathogen-associated molecular patterns (PAMPs) containing 5' triphosphate and double-stranded RN

178 ons, pathogen-associated molecular patterns (PAMPs) derived from pathogens and damage-associated mole

179 When pathogen-associated molecular patterns (PAMPs) displayed on the pathogen are recognized by Toll-

180 d by pathogen associated molecular patterns (PAMPs) during infection, including RNA and proteins from

181 Pathogen-associated molecular patterns (PAMPs) have the capacity to couple inflammatory gene exp

182 nize pathogen-associated molecular patterns (PAMPs) in microbial species.

183 and pathogen-associated molecular patterns (PAMPs) in oomycetes.

184 ling pathogen-associated molecular patterns (PAMPs) is a principal strategy used by fungi to avoid im

185 ) by pathogen-associated molecular patterns (PAMPs) is in essence sufficient to stop pathogen invasio

186 eive pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs).

187 wall pathogen-associated molecular patterns (PAMPs) orientate the host response toward either fungal

188 the pathogen-associated molecular patterns (PAMPs) responsible for T. denticola activation of the in

189 n of pathogen-associated molecular patterns (PAMPs) such as bacterial flagellin-derived flg22 trigger

190 s to pathogen-associated molecular patterns (PAMPs) that are conserved across broad classes of infect

191 rved pathogen-associated molecular patterns (PAMPs) that are recognized by pattern recognition recept

192 n of pathogen-associated molecular patterns (PAMPs) that are targeted to specific immune cells.

193 ense pathogen-associated molecular patterns (PAMPs) that are typical of whole classes of microbes.

194 p of pathogen-associated molecular patterns (PAMPs) that efficiently trigger innate immune activation

195 Pathogen-associated molecular patterns (PAMPs) that signal through Toll-like receptors (TLRs) ca

196 n of pathogen-associated molecular patterns (PAMPs) through pattern-recognition receptors (PRRs) on d

197 n- or microbe-associated molecular patterns (PAMPs) to elicit defenses and provide protection against

198 with pathogen-associated molecular patterns (PAMPs) to induce PAMP-triggered immunity (PTI) also rest

199 n of pathogen-associated molecular patterns (PAMPs) triggers a phosphorylation relay leading to PAMP-

200 n of pathogen-associated molecular patterns (PAMPs) was determined in patients with severe AH and in

201 ding pathogen-associated molecular patterns (PAMPs)(1).

202 iral Pathogen-Associated Molecular Patterns (PAMPs), and by the potential for 'arms race' coevolution

203 Ps), pathogen-associated molecular patterns (PAMPs), danger-associated molecular patterns (DAMPs), an

204 iple pathogen-associated molecular patterns (PAMPs), including beta-glucan.

205 n of pathogen-associated molecular patterns (PAMPs), such as bacterial flagellin (or the peptide flg2

206 iral pathogen-associated molecular patterns (PAMPs), such as double-strandedness and dsRNA blunt ends

207 n of pathogen-associated molecular patterns (PAMPs), such as LPS or other colonizing/invading microbe

208 rial pathogen associated molecular patterns (PAMPs), such as LPS, is well established to induce toler

209 s by pathogen-associated molecular patterns (PAMPs).

210 d by pathogen associated molecular patterns (PAMPs).

211 n of pathogen-associated molecular patterns (PAMPs).

212 iral pathogen-associated molecular patterns (PAMPs).

213 tent pathogen-associated molecular patterns (PAMPs).

214 ying pathogen-associated molecular patterns (PAMPs).

215 rved pathogen-associated molecular patterns (PAMPs).

216 d to pathogen-associated molecular patterns (PAMPs).

217 g to pathogen-associated molecular patterns (PAMPs).

218 rved pathogen-associated molecular patterns (PAMPs).

219 with pathogen-associated molecular patterns (PAMPs).

220 with pathogen-associated molecular patterns (PAMPs)/danger-associated molecular patterns, including d

221 iral pathogen-associated molecular patterns (PAMPs)/live virus, alone and in combination.

222 via pathogen-associated molecular patterns (PAMPs, such as lipopolysaccharides), which leads to prem

223 thogen/damage-associated molecular patterns (PAMPs/DAMPs) through pattern recognition receptors (PRRs

224 hogen/microbe-associated molecular patterns (PAMPs/MAMPs) and pathogen effectors.

225 n- or microbe-associated molecular patterns (PAMPs/MAMPs) are detected as nonself by host pattern rec

226 (or microbe)-associated molecular patterns (PAMPs/MAMPs) by pattern recognition receptors (PRRs) is

227 ogen-/microbe-associated molecular patterns (PAMPs/MAMPs) or damage-associated molecular patterns (DA

228 ngage pathogen-associated molecule patterns (PAMPs) present in viral products.

229 as "pathogen-associated molecular patterns" (PAMPs) or host-derived "damage-associated molecular patt

230 ens (pathogen-associated molecular patterns, PAMPs), whereas others bind endogenous plant compounds (

231 r with proadrenomedullin N-terminal peptide (PAMP), by the Adm gene (adrenomedullin gene).

232 ithin minutes of treatment with the peptidic PAMP flg22, which is derived from bacterial flagellin.

233 In OsPT8-OX plants, PAMPs-triggered immunity (PTI) response genes, such as O

234 hich selectively abrogated AM, but preserved PAMP, expression (Adm(AM+/Delta) animals).

235 tokine/chemokine production, thus preserving PAMP-mediated TLR4-MD-2 responses.

236 equesters chitin oligosaccharides to prevent PAMP-triggered immunity in rice, thereby facilitating ra

237 esponsiveness, even when the active purified PAMP has not been defined.

238 lular and endosomal receptors that recognize PAMPs from a wide range of microbial pathogens.

239 HBI1 overexpression leads to reduced PAMP-triggered responses.

240 A5) activation by double strandedness of RNA PAMPs (coating backbone) but is unable to inhibit activa

241 th pathogen-associated molecular pattern(s) (PAMPs) being presented by molecule(s) on one cell to spe

242 hibits immune responses triggered by several PAMPs and anti-bacterial immunity.

243 panosoma cruzi, which is deficient in strong PAMPs, we demonstrate a requirement for the continuous e

244 This technology can be applied to study PAMP-TLR interactions in diverse organisms.

245 HKPG and PG-LPS differentially suppress PAMP-induced TNFalpha, IL-6 and IL-10 but fail to suppre

246 the resistance protein Rpi-blb2, suppresses PAMP-triggered immunity (PTI) and promotes pathogen colo

247 and later responses triggered by all tested PAMPs, suggestive of a role in signaling.

248 Previous evidences suggest that PAMP-triggered immunity (PTI) is under constant negative

249 er in length and complexity, suggesting that PAMP diversity in T/F genomes could regulate innate immu

250 These findings demonstrate that PAMPs function to potentiate adaptive immune responses w

251 o mice, and in vitro experiments showed that PAMPs, but not alcohol, directly induced LCN2 and CXCL1.

252 lation of these residues is critical for the PAMP-induced ROS burst and antibacterial immunity.

253 d calcium-dependent immunity programs in the PAMP-triggered immunity signalling pathway in plants.

254 ending upon identity and localization of the PAMP.

255 se results unveil the impact of HopM1 on the PAMP-triggered oxidative burst and stomatal immunity in

256 triggered immunity, CRT1 interacted with the PAMP recognition receptor FLS2.

257 In the absence of PDIM, these PAMPs signal a Toll-like receptor (TLR)-dependent recrui

258 This PAMP-independent effect of SA causes a transient reducti

259 Inherent in the existence of this PAMP is the concomitant existence of a molecular sensor

260 to cleave and limit the accumulation of this PAMP.

261 ing molecules, exert limited effects on this PAMP.

262 re investigated, understanding the known TLR-PAMP interactions, through the exploitation of this elec

263 particles (SVLPs) carrying hydrophobic TLR2 PAMPs within di- and triacylated lipopeptide cores (P2Cy

264 ecognized intracellular exposure of the TLR2 PAMPs carried by di- and triacylated SVLP cores, which i

265 showed that PBS3 and EDS1 also contribute to PAMP-triggered immunity in addition to effector-triggere

266 triggers a phosphorylation relay leading to PAMP-triggered immunity (PTI).

267 the insensitivity of g6pd6 mutant plants to PAMP-induced growth inhibition was complemented by a pho

268 nition receptors (PRRs), which gives rise to PAMP-triggered immunity (PTI).

269 potentiates the responsiveness of plants to PAMPs.

270 They can also respond to PAMPs, but the previous encounter of inflammatory signal

271 e modes of signaling for PRRs in response to PAMPs and SA.

272 phosphorylated and activated in response to PAMPs.

273 had greatly diminished hepcidin response to PAMPs.

274 , and plants are rendered more responsive to PAMPs.

275 and ACD6-dependent reduced responsiveness to PAMPs.

276 high expression of AID, high sensitivity to PAMPs, and the ability to produce cytokines.

277 affects the responsiveness of plants to two PAMPs.

278 length of the U-core motif of the poly-U/UC PAMP and are recognized by RIG-I to induce innate immune

279 al cell wall peptidoglycan (CW), a universal PAMP for TLR2, traverses the murine placenta into the de

280 The perception of several unrelated PAMPs rapidly induced ASKalpha kinase activity.

281 gered by the perception of several unrelated PAMPs.

282 In contrast to its expression pattern upon PAMP treatment, HBI1 expression is enhanced by BR treatm

283 interacts with and phosphorylates RBOHD upon PAMP perception.

284 turnover of PUB22, which is stabilized upon PAMP perception.

285 IFN responses induced by CS plus virus/viral PAMP in combination.

286 These studies demonstrate that CS and viral PAMPs/live virus interact in a synergistic manner to sti

287 While the exact nature of the viral PAMPs remains to be determined, our data suggest that in

288 ling responses induced by CS and virus/viral PAMPs in lungs from RNase L null and wild-type mice.

289 erimental system the major influenza A virus PAMPs are distinct from those of incoming genomes or pro

290 identify prokaryotic messenger RNA as a vita-PAMP present only in viable bacteria, the recognition of

291 ate in live Gram-positive bacteria is a vita-PAMP, engaging the innate sensor stimulator of interfero

292 y STING-dependent sensing of a specific vita-PAMP and elucidate how innate receptors engage multilaye

293 This vita-PAMP-induced ER-phagy additionally orchestrates an inter

294 Vita-PAMPs denote microbial viability, signaling the danger o

295 Detection of vita-PAMPs triggers a state of alert not warranted for dead b

296 al class of viability-associated PAMPs (vita-PAMPs).

297 Hepatic inflammation was associated with PAMP translocation and lipocalin-2 (LCN2) and chemokine

298 and innate immune activation correlate with PAMP sequence characteristics.

299 cated into the host cell and interferes with PAMP-triggered immunity (PTI).

300 d SGT1, are suppressed during treatment with PAMPs chitin or flg22.